Originally published In Press as doi:10.1074/jbc.M001557200 on May 23, 2000
J. Biol. Chem., Vol. 275, Issue 31, 23500-23508, August 4, 2000
Replication Protein A Physically Interacts with the Bloom's
Syndrome Protein and Stimulates Its Helicase Activity*
Robert M.
Brosh Jr.
,
Ji-Liang
Li§¶,
Mark K.
Kenny
,
Julia K.
Karow§¶
**,
Marcus P.
Cooper
,
Raichal P.
Kureekattil
,
Ian D.
Hickson§
, and
Vilhelm A.
Bohr

From the
Laboratory of Molecular Genetics, NIA,
National Institutes of Health, Baltimore, Maryland 21224, § The
Imperial Cancer Research Fund Laboratories, Institute of
Molecular Medicine, University of Oxford, John Radcliffe Hospital,
Oxford OX3 9DS, United Kingdom, and the
Montefiore Medical
Center, Department of Radiation Oncology and the Albert Einstein Cancer
Center, Bronx, New York 10467
Received for publication, February 24, 2000, and in revised form, May 17, 2000
 |
ABSTRACT |
Bloom's syndrome is a rare autosomal recessive
disorder characterized by genomic instability and predisposition to
cancer. BLM, the gene defective in Bloom's syndrome,
encodes a 159-kDa protein possessing DNA-stimulated ATPase and
ATP-dependent DNA helicase activities. We have examined
mechanistic aspects of the catalytic functions of purified recombinant
BLM protein. Through analyzing the effects of different lengths of DNA
cofactor on ATPase activity, we provide evidence to suggest that BLM
translocates along single-stranded DNA in a processive manner. The
helicase reaction catalyzed by BLM protein was examined as a function
of duplex DNA length. We show that BLM catalyzes unwinding of short DNA
duplexes (
71 base pairs (bp)) but is severely compromised on longer
DNA duplexes (
259-bp). The presence of the human single-stranded DNA-binding protein (human replication protein A (hRPA)) stimulates the
BLM unwinding reaction on the 259-bp partial duplex DNA substrate. Heterologous single-stranded DNA-binding proteins fail to stimulate similarly the helicase activity of BLM protein. This is the first demonstration of a functional interaction between BLM and another protein. Consistent with a functional interaction between hRPA and the
BLM helicase, we demonstrate a direct physical interaction between the
two proteins mediated by the 70-kDa subunit of RPA. The interactions
between BLM and hRPA suggest that the two proteins function together
in vivo to unwind DNA duplexes during replication, recombination, or repair.
 |
INTRODUCTION |
Bloom's syndrome (BS)1
is a rare autosomal recessive disorder characterized by pre- and
postnatal growth retardation, immunodeficiency, sun-induced facial
erythema, and a greatly increased predisposition to a wide range of
malignant cancers (1). The most characteristic feature of cells from BS
patients is genomic instability (for review, see Ref. 2). This is
manifested predominantly as an elevated frequency of chromosome breaks
and exchanges (1, 3, 4) as well as a characteristic increase in the
level of reciprocal exchanges between sister chromatids (5). BS cells
exhibit hyper-recombination (1, 6, 7) and abnormalities in DNA
replication that include an extended S phase and accumulation of
abnormal replication intermediates compared with normal cells
(8-10).
The gene defective in BS, designated BLM, encodes a protein
of 1417 amino acids with the seven conserved motifs found in RNA and
DNA helicases (7). By sequence alignment, the BLM gene product
belongs to the RecQ subfamily of DNA helicases that includes a single
Escherichia coli DNA helicase named RecQ, a protein required for the RecF pathway of genetic recombination (11) and for suppression of illegitimate recombination (12). Two yeast proteins,
Saccharomyces cerevisiae Sgs1p (13, 14) and
Schizosaccharomyces pombe Rqh1p (15), belong to the RecQ
subfamily and have proposed roles in recombination and possibly
replication. At present, five human members of the RecQ subfamily have
been identified, including BLM (7), WRN (16), RecQL (17), RecQL4
(18), and RecQL5 (18). Mutations in the WRN gene are
responsible for the premature aging disorder Werner's syndrome (16).
Most recently, it was demonstrated that mutations in the
RecQL4 gene result in some cases of Rothmund-Thomson's
syndrome (19). Both Werner's syndrome (20, 21) and Rothmund-Thomson's
syndrome (22), like BS, are characterized by chromosomal instability
suggesting that DNA helicases are important caretakers of the human
genome with specialized roles in pathways of DNA metabolism.
Biochemical studies have shown that the BLM protein is a DNA-stimulated
ATPase and ATP-dependent helicase, catalyzing strand displacement of short and medium length oligonucleotides (
91 bp) from
partial duplex substrates with a 3' to 5' polarity (23). BLM helicase
preferentially unwinds a G4 DNA substrate consisting of four
guanine-rich strands stabilized by Hoogsteen bonding (24). Electron
microscopy analysis has shown that BLM protein forms oligomeric rings
in solution (25). Size exclusion chromatography data indicate that the
majority of enzymatically active BLM has an apparent molecular mass of
>700 kDa, which is consistent with an oligomeric structure for BLM
(25).
Aside from these structural and biochemical data, molecular details of
the interactions of BLM protein with other proteins and biological DNA
substrates remain to be defined. The molecular deficiencies involved in
the clinical phenotype of BS presumably reflect an impaired function of
the BLM protein in a pathway of nucleic acid metabolism. Transfection
of the wild-type BLM gene into BS cells reduces the
frequency of sister chromatid exchanges (26). Mutant alleles of
BLM found in individuals with clinical BS encode BLM protein
that is devoid of DNA helicase activity and fails to reduce the high
sister chromatid exchanges in transfected BS cells (26, 27). These
studies provide evidence that the enzymatic activity of BLM is
important for its cellular function.
In an effort to better understand the mechanistic aspects of the BLM
catalytic activities, we have further characterized the catalytic
activities of the BLM protein. Our results show that BLM unwinds short
DNA duplexes (
71 bp) but is severely compromised on DNA duplexes
259 bp. The poor unwinding of BLM helicase on relatively long DNA
duplex substrates suggested to us that additional protein factor(s)
might convert the helicase into a more processive enzyme. A good
candidate to serve as an accessory factor to BLM helicase is the
heterotrimeric single-stranded DNA-binding protein RPA that has been
implicated in replication, recombination, and DNA repair (28). Evidence
indicates that RPA modulates these processes by specific
protein-protein and protein-DNA interactions. We have recently
demonstrated that a specific functional and physical interaction exists
between human RPA and WRN helicase (29). WRN helicase was found to be
capable of unwinding long DNA duplexes up to 849 bp in a reaction
dependent on hRPA. The notion that RPA may coordinately function with
BLM helicase in vivo is supported by the recent finding that
BLM colocalizes with RPA in meiotic prophase nuclei of mammalian
spermatocytes (30). Colocalization of BLM and RPA at the synaptonemal
complex of homologously synapsed autosomal bivalents suggests that
these foci mark sites of ssDNA synaptic-related meiotic activity. The
interactive roles of BLM and hRPA on synapsed meiotic bivalents are
undefined but likely to involve the catalytic activity of BLM protein.
In this study we have shown that RPA is required to support BLM
helicase activity on a relatively long DNA duplex of 259-bp. Two
heterologous SSBs, ESSB and gp32, failed to substitute for RPA. This
functional interaction was further substantiated by the demonstration
of a physical interaction between hRPA and BLM. This interaction, and
colocalization of the two proteins in meiotic cells, suggests that BLM
and RPA function together in a pathway of DNA metabolism such as
recombination or replication.
 |
MATERIALS AND METHODS |
Proteins--
Recombinant hexahistidine-tagged BLM protein was
overexpressed in Saccharomyces cerevisiae and purified as
described previously (25). hRPA containing all three subunits (RPA70,
RPA32, and RPA14) was purified as described previously (31). S. cerevisiae replication protein A (scRPA) was a generous gift of
Drs. Dan Bean and Steven Matson, University of North Carolina, Chapel
Hill. ESSB was purchased from Promega. T4 gp32 was from U. S.
Biochemical Corp. Restriction endonuclease HaeIII was
obtained from New England Biolabs. Klenow enzyme was obtained from
Roche Molecular Biochemicals. DNase I was from Roche Molecular
Biochemicals. BSA type V was from ICN Biochemicals.
Nucleotides and DNA--
M13mp18 ssDNA was from New England
Biolabs. The 28-mer oligonucleotide 5'-TCCCAGTCACGACGTTGTAAAACGACGG-3'
was from Life Technologies, Inc. M13mp18 RFI was prepared as described
previously (32). (dT)~263 and ATP were from Amersham
Pharmacia Biotech. (dT)~900 was from Midland Certified
Reagent Co. [3H]ATP was from Amersham Pharmacia Biotech,
and [
-32P]dCTP was from NEN Life Science Products.
DNA Helicase Substrates--
The 71-, 259-, and 851-bp M13mp18
partial duplex substrates were constructed as described previously (29,
33) with the following modifications. Duplex DNA fragments (69-, 257-, and 849-bp) from the HaeIII digest of M13mp18 replicative
form were purified by polyacrylamide gel electrophoresis and
electroelution. The desired restriction fragment (100 ng) and M13mp18
ssDNA circle (2 µg) were incubated together in an annealing reaction.
The resulting partial duplex was labeled at its 3' terminus in a
fill-in reaction with [32P]dCTP and Klenow enzyme. The
30-bp M13mp18 partial duplex substrate was constructed with a 28-mer
complementary to positions 6296-6323 in M13mp18. The 28-mer was
annealed to M13mp18 ssDNA circle and labeled at its 3' end as described
above. Partial duplex DNA substrates were purified by gel filtration
column chromatography using Bio-Gel A-5M resin (Bio-Rad).
DNA Helicase Assay--
Helicase assay reaction mixtures (20 µl) contained 50 mM Tris-HCl (pH 7.4), 5 mM
MgCl2, 5 mM ATP, 100 µg/ml bovine serum
albumin, 50 mM NaCl, and the indicated amounts of BLM
helicase and/or single-stranded DNA-binding protein. The concentration
of the 30-, 71-, 259-, and 851-bp partial duplex helicase substrates in
the reaction mixture was approximately 2 µM (nucleotide).
Reactions were initiated by the addition of BLM protein and incubated
at 37 °C for the indicated times. Reactions were terminated by the
addition of 10 µl of 50 mM EDTA, 40% glycerol, 0.9%
SDS, 0.1% bromphenol blue, 0.1% xylene cyanol. The products of
helicase reactions with the 30-, 71-, 259-, and 851-bp partial duplex
substrates were resolved on 12, 8, 6, and 6% nondenaturing
polyacrylamide gels, respectively, as described previously (29).
Radiolabeled DNA species in polyacrylamide gels were visualized using a
PhosphorImager or film autoradiography and quantitated using the
ImageQuant software (Molecular Dynamics). The percent helicase
substrate unwound was calculated by the following formula: % displacement = 100 × P/(S + P). P is the product volume and
S is the substrate volume. The values for P and S have been corrected
after subtracting background values in the no enzyme and heat-denatured
controls, respectively. All helicase data represent the average of at
least three independent determinations.
ATPase Assay--
Standard ATPase assay reaction mixtures (30 µl) contained 50 mM Tris-HCl (pH 7.4), 5 mM
MgCl2, the indicated ssDNA effector (30 µM
nucleotide), 0.8 mM [3H]ATP (42 cpm/pmol), 13 nM BLM protein, and the indicated amounts of hRPA.
Reactions were initiated by the addition of BLM protein and incubated
at 37 °C. Samples (5 µl) were removed at 2-min intervals and
evaluated by thin layer chromatography as described previously (34).
Less than 20% of the substrate ATP was consumed in the reaction over
the entire time course of the experiment. The kinetic rate constant
(kcat) values were expressed as the mean of at
least three independent determinations.
ELISA Method for Detection of BLM-hRPA Protein-Protein
Interaction--
hRPA was diluted to a concentration of 1.65 ng/µl
in Carbonate Buffer (0.016 M
Na2CO3, 0.034 M NaHCO3
(pH 9.6)). hRPA was then added to the appropriate wells of a 96-well
ELISA plate (100 µl/well) and allowed to incubate for 2 h at
24 °C. For control experiments, BSA was substituted for hRPA in the
coating step. Wells were aspirated and washed three times with Wash
Buffer (PBS, 0.5% Tween 20). Blocking Buffer (PBS, 0.5% Tween 20, 3%
BSA) was added to appropriate wells and allowed to incubate 2 h at
24 °C. Wells were aspirated and washed one time with Blocking
Buffer. BLM protein was diluted to 1.0 ng/µl in Binding Buffer (50 mM Tris-HCl (pH 7.4), 5 mM MgCl2, 5 mM ATP, 100 µg/ml BSA, and 50 mM NaCl, or the
indicated NaCl concentration). The diluted BLM protein was then added
to appropriate wells of the ELISA plate (100 µl/well) and allowed to
incubate for 30 min at 24 °C. Wells were aspirated and washed three
times with Binding Buffer. Primary antibody (rabbit polyclonal IgG
against BLM protein) was diluted 1:1000 in Blocking Buffer, added to
appropriate wells, and allowed to incubate 1 h at 24 °C. Wells
were aspirated and washed four times with Blocking Buffer. Secondary
antibody (goat anti-rabbit IgG-horseradish peroxidase) (Jackson
ImmunoResearch) was diluted 1:10,000 in Conjugate Buffer (50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 0.05% Tween
20, 1% BSA), added to appropriate wells, and allowed to incubate 30 min at 24 °C. Wells were aspirated and washed five times with
Conjugate Buffer. Complexes were detected using K-Blue substrate
(Biogen Corp.). The reaction was terminated after 1 min with 1 N sulfuric acid. Absorbance readings were taken at 450 nm.
The A450 values, corrected for background
signal in the presence of BSA, are expressed as the mean of three
independent determinations.
For DNase I treatment, both BLM protein and hRPA were pretreated with
20 units of DNase I in Binding Buffer at 37 °C for 15 min. The
proteins were subsequently used in the ELISA as described above. Under
the conditions used for DNase I treatment, 250 ng of control DNA
standard (DNA Molecular Weight Marker II, Roche Molecular Biochemicals)
was completely degraded (<2.5 ng, detectable limit) as evidenced by
SYBR Green Stain (FMC Bioproducts) detection of DNA electrophoresed on
a 1% agarose gel.
Data Analysis--
The fraction of the immobilized hRPA bound to
the microtiter well that was specifically bound by BLM protein was
determined from the ELISAs. A Hill plot was used to analyze the data
(Equations 1 and 2).
|
(Eq. 1)
|
|
(Eq. 2)
|
Kd is the dissociation constant of the
BLM·hRPA complex, [Pt] is the total concentration of BLM protein
present in the reaction, and f is the ratio of the amount of
the bound hRPA over the total amount of hRPA in the reaction. The
logarithm of [Pt] was plotted against the logarithm of
(f/(1
f)), and the y intercept
represented the logarithm of Kd.
Far Western Blotting--
Far Western blotting analysis was
conducted essentially as described by Wu et al. (35).
Previously, a physical interaction between BLM and hTOPIII
was
demonstrated (35). In these studies, the BLM-hTOPIII
interaction
served as a positive control in experiments to detect a BLM-hRPA
interaction. Briefly, 0.2-1.0 µg of each polypeptide was subjected
to SDS-polyacrylamide gel electrophoresis and transferred to Hybond-ECL
filters (Amersham Pharmacia Biotech). All subsequent steps were
performed at 4 °C. Filters were immersed twice in denaturation
buffer (6 M guanidine HCl in PBSA) for 10 min followed by 6 times for 10 min in serial dilutions (1:1) of denaturation buffer
supplemented with 1 mM dithiothreitol. Filters were blocked
in TBS containing 10% powdered milk, 0.3% Tween 20 for 30 min before
being incubated in BLM (0.5 µg/ml) in TBS supplemented with 0.25%
powdered milk, 0.3% Tween 20, 1 mM dithiothreitol, and 1 mM phenylmethylsulfonyl fluoride for 60 min. Filters were washed for 4 times for 10 min in TBS containing 0.3% Tween 20, 0.25%
powdered milk. The second wash contained 0.0001% glutaraldehyde. Conventional Western analysis was then performed to detect the presence
of BLM using BFL-103 (35) as primary antibody. Anti-mouse IgG/horseradish peroxidase conjugate (Sigma) was used as secondary antibody at a 1:10,000 dilution and detected using ECL (Amersham Pharmacia Biotech) following the manufacturer's instructions.
 |
RESULTS |
Characterization of ATP Hydrolysis Catalyzed by Bloom
Protein--
BLM helicase, like all helicases characterized to date,
hydrolyzes nucleoside triphosphate as an energy source for the
unwinding reaction (36). We studied the DNA-stimulated ATPase activity of BLM protein in the presence of DNA cofactors of varying lengths. Results of these assays are summarized in Table
I. In the absence of a DNA effector,
little or no ATP hydrolysis by BLM protein could be detected using a
thin layer chromatography method to measure conversion of
[3H]ATP to [3H]ADP. These results are
consistent with the strong stimulation of ATP hydrolysis by DNA
effectors reported by Karow et al. (23). With the very short
(dT)16 oligonucleotide, the turnover rate constant
kcat for ATP hydrolysis was 141 min
1. As the length of the dT tract was
increased to an average length of 263 nt, the
kcat increased nearly 6-fold. Increasing the dT tract from 263 to 900 nt resulted in only a modest 1.2-fold increase in
the kcat for ATP hydrolysis. By using M13 ssDNA
circles as an infinitely long DNA effector, the increase in
kcat to 1163 min
1 was
similarly modest (1.2-fold). However, we cannot rule out that very long
ssDNA molecules would result in a significantly greater ATPase activity
of BLM since the M13 ssDNA circle contains secondary structure. These
data indicate that the stimulatory effect of DNA molecules on BLM ATP
hydrolysis begins to plateau at a poly(dT) tract length of
approximately 263 nt.
View this table:
[in this window]
[in a new window]
|
Table I
Hydrolysis of ATP (kcat) catalyzed by BLM in the presence of
various DNA effectors
The BLM concentration was 13 nM (monomer).
|
|
The stimulation of BLM protein ATPase activity by a given DNA
concentration (30 µM nucleotide phosphate) was much
greater for long dT tracts (263 and 900). To investigate if the BLM
ATPase reaction was saturated with respect to each DNA effector, we
examined BLM protein ATP hydrolysis in the presence of a 3-fold greater concentration of nucleotide phosphate (90 µM) for each
DNA effector. The initial rates of BLM ATP hydrolysis were not
increased with the elevated nucleotide phosphate concentration for each
of the DNA effectors (data not shown). These data provide evidence that the ATPase reaction is saturated with respect to ssDNA for each DNA
effector under the reaction conditions used.
The data in Table I might be interpreted to suggest that the free ends
of the DNA effector molecules are inhibitory to the ATP hydrolysis
reaction of BLM protein. To address this possibility, we mixed
(dT)16 with either (dT)~900 or M13 ssDNA at a
3:1 molar ratio of nucleotide phosphate and tested the mixture in BLM
ATPase reactions. The kcat values for
BLM-catalyzed ATP hydrolysis in the presence of the
(dT)~900 + (dT)16 mixture or M13 ssDNA + (dT)16 mixture were 921 and 1022 min
1, respectively (Table I). These data
indicate that the BLM ATPase reaction stimulated by
(dT)~900 or M13 ssDNA was not inhibited by the presence
of the short (dT)16 molecules, suggesting that the DNA ends
do not inhibit ATP hydrolysis.
Effect of Duplex Length on the BLM Helicase
Reaction--
Helicases can be classified by the macroscopic reaction
mechanism for unwinding (36). Duplex unwinding as a function of duplex
length is an important property of each helicase and may yield insights
into the biochemical role of the enzyme in the cell. By using a variety
of DNA substrates, biochemical studies of purified helicases in
vitro have demonstrated that each DNA unwinding enzyme exhibits
its own characteristic dependence of unwinding on DNA duplex length.
To characterize the effect of duplex length on the unwinding activity
of BLM helicase, we tested partial duplex substrates of varying length
in a strand displacement assay. Unwinding of M13 partial duplex DNA
substrate molecules of 30, 71, 259, and 851 bp was measured as a
function of BLM protein concentration (Fig.
1). The figures for percent unwinding of
the 30- (Fig. 1A) and 71-bp (Fig. 1B) substrates
rose to 70 and 37% with 4 nM BLM and 92 and 65% with 16 nM BLM (Fig. 1C). Further increase in amount of
BLM helicase in the reaction did not result in an increase in the
percent of DNA unwound for either substrate. The molecular explanation
for the inability to achieve a greater percentage of the 71-bp partial
duplex DNA substrates unwound is not clear. This phenomenon has been
previously observed for UvrD helicase (33) and may reflect strand
reannealing during the unwinding reaction (discussed below).

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 1.
BLM helicase catalyzes a limited
unwinding reaction. Helicase assays were as described under
"Materials and Methods" using the indicated concentration of BLM
protein and M13mp18 partial duplex substrates of 30 bp (A),
71 bp (B), 259 bp (not shown), and 851 bp (not shown).
Incubation was at 37 °C for 1 h. Reaction products were
analyzed by nondenaturing gel electrophoresis. , heat-denatured
control. C, quantitation of results from helicase assays.
, 30 bp; , 71 bp; ×, 259 bp; , 851 bp. Percent displacement
is expressed as a function of BLM protein concentration.
|
|
These results demonstrate that BLM helicase is not a very processive
helicase even on short DNA duplexes, since the fraction of partial
duplex molecules unwound exhibits a strict dependence on length of
duplex. Rather, the amount of BLM helicase that is required in the
unwinding reaction for the 30- and 71-bp partial duplex substrates is
proportional to the length of DNA duplex to be unwound.
It is useful to express the strand displacement data as a rate of base
pairs unwound per min per BLM helicase monomer (bp/min/BLM monomer). At
a BLM concentration of 2 nM, the rates of duplex unwinding
were 0.033 bp/min/BLM monomer for the 30-bp duplex substrate and 0.039 bp/min/BLM monomer for the 71-bp duplex substrate. At a BLM
concentration of 4 nM, the rate of unwinding was 0.024 bp/min/BLM monomer for the 30-bp duplex substrate and 0.030 bp/min/BLM
monomer for the 71-bp duplex substrate. Thus, the rates of unwinding
(bp unwound/min/BLM monomer) were very similar for both the 30- and 71-bp partial duplex. Thus the number of base pairs unwound by BLM
helicase for short (
71 bp) partial duplex DNA substrates depends on
the amount of BLM protein in the reaction as opposed to the length of
the duplex unwound.
In contrast to the data described above, the 259- and 851-bp partial
duplex substrates were very poorly unwound by BLM helicase at all
protein concentrations tested. BLM protein displaced less than 2% of
the 259-mer DNA fragments on the helicase substrate (Fig.
1C) and produced no detectable unwinding of the 851-bp
partial duplex substrate (Fig. 1C). Increasing the BLM
concentration did not result in a proportional increase of percent
substrate unwound (Fig. 1C). The maximum rate of unwinding
(bp unwound/min/BLM monomer) was 13-fold less for the 259-bp partial
duplex compared with the 71-bp partial duplex. These results indicate
that BLM helicase unwinds short DNA duplexes (
71 bp) efficiently but
is severely compromised in its ability to unwind longer DNA duplexes.
We conclude that BLM helicase catalyzes a limited unwinding reaction
in vitro.
Specific Stimulation of BLM Helicase Activity by RPA--
The
limited unwinding reaction catalyzed by BLM helicase suggests that the
enzyme encounters some type of kinetic barrier that prevents the
unwinding of long duplex DNA tracts. Although there are a number of
possible explanations for this result, we sought to test the effect of
SSBs on the unwinding reaction. Previously, we demonstrated that a
specific functional and physical interaction exists between WRN
helicase and human replication protein A, which allows the enzyme to
catalyze efficient unwinding of long DNA duplexes (29). Hence, an
additional protein factor such as hRPA may be required to convert BLM
helicase into a more processive enzyme. Alternatively, the poor ability
of BLM helicase to unwind long duplex regions may be due to reannealing
of the two strands of the DNA behind the advancing helicase. In the
latter case, an SSB of any source may be suitable for stimulation of
BLM helicase activity on long DNA duplexes.
To test the effect of the single-stranded DNA-binding protein, hRPA, on
BLM unwinding activity, BLM protein was incubated with the 259-bp
partial duplex in the presence of different concentrations of hRPA
(Fig. 2). BLM protein (32 nM)
alone catalyzed very little detectable unwinding (~3%) of the 259-bp
partial duplex DNA substrate. In control reactions, hRPA (384 nM heterotrimer) alone also did not denature the 259-bp
partial duplex DNA substrate (Fig. 2A). However, activation
of BLM helicase activity on the 259-bp partial duplex could be detected
at hRPA concentrations as low as 96 nM (heterotrimer)
(~32% substrate unwound) (Fig. 2, A and B). A
1.5-fold increase in hRPA concentration (144 nM,
heterotrimer) resulted in stimulating BLM helicase activity to 75%
substrate unwound. Maximal unwinding of the 259-bp partial duplex
(82%) was achieved at an hRPA concentration of 192 nM
heterotrimer.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 2.
Stimulation of BLM helicase activity on a
259-bp partial duplex DNA substrate by hRPA. A, BLM
protein (32 nM) was incubated with the 259-bp partial
duplex in the presence of the indicated concentrations of hRPA under
standard helicase reaction conditions. Incubation was at 37 °C for
1 h. B, quantitation of results obtained in
A. Percent displacement is expressed as a function of hRPA
concentration. Inset, quantitation of results obtained in
A. Percent displacement is expressed as a function of the
ratio, (SSB binding unit)/(DNA binding unit).
|
|
To determine if the stimulatory effect of hRPA on BLM helicase activity
reflected a specific functional interaction between the two molecules,
the effects of ESSB and T4 gp32 on BLM-catalyzed unwinding of the
259-bp partial duplex were tested. In control reactions, ESSB (1456 nM homotetramer) or T4 gp32 (6042 nM monomer) alone did not denature the 259-bp partial duplex DNA substrate (data
not shown). At all concentrations tested, neither ESSB (0-1456 nM homotetramer) nor T4 gp32 (0-6042 nM
monomer) stimulated BLM helicase to unwind the 259-bp duplex over
background (data not shown).
To gain insight into the mechanism of stimulation of BLM helicase
activity by hRPA, strand displacement was expressed as a function of
the ratio (R) of SSB-binding units per DNA-binding site. This analysis
takes into account the fact that one ESSB homotetramer binds 35 nt
(37); one gp32 monomer binds 7 nt (37), and one hRPA heterotrimer binds
30 nt (28). The stimulation of BLM helicase activity on the 259-bp
partial duplex substrate was first detectable at a 1.5-fold excess of
hRPA heterotrimer binding units compared with ssDNA-binding sites for
hRPA (r = 1.5) (Fig. 2B, inset). At an R
value of 2, the hRPA-stimulated BLM unwinding reaction attained a value
of 75% substrate unwound, approaching the maximum. In contrast, ESSB
failed to stimulate BLM helicase activity at a 25-fold excess of ESSB
binding equivalents over ESSB-binding sites (data not shown). Likewise,
gp32 failed to stimulate BLM helicase activity at a 21-fold excess of
binding units compared with binding sites (data not shown). The fact
that both ESSB and T4 gp32 failed to stimulate unwinding of the long DNA duplex suggests that a specific interaction between BLM helicase and hRPA might be responsible for the observed unwinding of the 259-bp
DNA duplex. The unique requirement for RPA to stimulate BLM-catalyzed
unwinding of a long DNA duplex suggests that this functional
interaction may also be important in vivo.
Effect of S. cerevisiae RPA on BLM Helicase Activity--
The
evolutionary conservation of eukaryotic RPA homologues suggests that
RPA may have similar functions in DNA metabolism in eukaryotic
organisms (28). However, a number of in vitro studies have
demonstrated that RPA homologues are not functionally equivalent (28,
38). It is presumed that species-specific interactions of RPA with DNA
and other proteins are responsible for the differences. To examine this
issue in the context of BLM function, we tested RPA from S. cerevisiae for its effect on the BLM helicase reaction. BLM
protein (32 nM, monomer) was incubated with the 259-bp
partial duplex in the presence of the indicated concentrations of scRPA
(Fig. 3). In control reactions, scRPA (300 nM, heterotrimer) alone did not denature the 259-bp
partial duplex substrate. At an scRPA concentration of 12.5 nM heterotrimer, approximately 40% of the 259-bp partial
duplex substrate was unwound. The percent substrate unwound achieved a
maximum of approximately 70% at an scRPA concentration of 300 nM heterotrimer. These results indicate that scRPA can
effectively substitute for hRPA in the stimulation of BLM helicase
activity on a long 259-bp DNA duplex. Indeed, on a mole for mole basis,
scRPA was more effective than hRPA in stimulating BLM helicase activity
at significantly lower concentrations than hRPA. There are a number of
possible explanations for the observed differences; for example, hRPA
was overexpressed in E. coli, whereas scRPA was
overexpressed in its native organism, potentially influencing the
specific activity of the two proteins.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 3.
S. cerevisiae RPA stimulates BLM
helicase activity. BLM protein (32 nM) was incubated
with the 259-bp partial duplex in the presence of the indicated
concentrations of scRPA under standard helicase reaction conditions.
Incubation was at 37 °C for 1 h. Percent displacement is
expressed as a function of scRPA concentration. Inset,
quantitation of results. Percent displacement is expressed as a
function of the ratio, (SSB binding unit)/(DNA binding unit).
|
|
Effect of Duplex Length on BLM Helicase Reaction in the Presence of
hRPA--
As described above, at concentrations of BLM protein
4
nM, the rates of unwinding the 30- and the 71-bp partial
duplex substrates were very similar in the absence of hRPA (Fig. 1).
However, for longer duplexes (259 and 851 bp), helicase activity was
hardly detectable. One of the possible explanations for the ability of hRPA to stimulate BLM helicase activity on the 259-bp partial duplex is
that hRPA converts BLM helicase into a more processive enzyme. To
examine more closely the stimulatory effect of hRPA on the BLM
unwinding reaction, we tested the effect of hRPA on BLM helicase
activity using the different length partial duplex DNA substrates (Fig.
4). The same levels of BLM protein were
used in these experiments as were used to measure unwinding in the absence of hRPA (Fig. 1). The concentration of hRPA in these studies was 144 nM heterotrimers, a 2-fold excess of hRPA
binding equivalents over binding sites on the helicase substrate.
This concentration of hRPA was chosen because BLM helicase activity on
the 259-bp partial duplex was stimulated to a near maximum (75%
substrate unwound) at this level (Fig. 2).

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 4.
Stimulatory effect of hRPA on BLM helicase
activity is dependent on duplex length. BLM protein (indicated
concentrations) was incubated with the 30- ( ), 71- ( ), 259- (×),
and 851-bp ( ) partial duplex DNA substrates in the presence of hRPA
(145 nM heterotrimer) under standard helicase reaction
conditions. Incubation was at 37 °C for 1 h. Reaction products
were analyzed by nondenaturing gel electrophoresis. Percent
displacement is expressed as a function of BLM protein
concentration.
|
|
The results of BLM protein titrations on the 30-, 71-, 259-, and 851-bp
partial duplex substrates in the presence of hRPA are shown in Fig. 4.
By using the 30-bp partial duplex, significant unwinding (~77%) was
achieved at a relatively low concentration of BLM protein (2 nM, monomer). At the same concentration of BLM protein,
27% of the 71-bp partial duplex was unwound. These results show that
BLM helicase still exhibits a protein
concentration-dependent reaction mechanism even on short
duplexes since the percent partial duplex substrate unwound at a given
BLM protein concentration is clearly less for the 71-bp duplex than for
the 30-bp duplex. This finding was further supported by an analysis of
the helicase data using the 259-bp partial duplex. Very little
unwinding of the 259-bp partial duplex (<1%) could be detected at a
BLM concentration of 2 nM. Thus, even in the presence of
hRPA, the percent fragment displaced by BLM helicase was significantly
reduced for the 259-bp duplex compared with the shorter 30- and 71-bp
duplexes. These results suggest that even in the presence of hRPA, the
BLM unwinding reaction is compromised on long DNA duplexes. However, at
higher concentrations of BLM protein, the presence of hRPA stimulates BLM helicase to more robustly unwind the 259-bp duplex, a finding consistent with the results presented in Fig. 2. The percent of 259-bp
partial duplex substrate unwound increased proportionately with BLM
protein concentrations. At the highest concentration of BLM tested, 64 nM monomer, 56% of the 259-bp partial duplex substrate
molecules in the reaction was unwound.
In these experiments, the rate of helicase activity on the 259-bp
partial duplex substrate achieves a maximum of 0.014 bp/min/BLM monomer
at a BLM protein concentration of 32 nM. This rate is closely matched by similar values of 0.012 and 0.011 bp/min/BLM monomer
at BLM concentrations of 16 and 64 nM, respectively. The maximal rates of BLM helicase activity in the presence of hRPA on the
30- and 71-bp partial duplex substrates were 0.053 and 0.044 bp/min/BLM
monomer. This rate analysis demonstrates a 3.8- and 3.1-fold
enhancement of unwinding the short 30- and 71-bp duplex substrates,
respectively, compared with the longer 259-bp substrate. These data
suggest that the efficiency of BLM-catalyzed unwinding is reduced even
in the presence of hRPA on longer DNA duplex substrates. However, the
presence of hRPA is required to support BLM helicase activity on DNA
duplexes of at least 259 bp.
In contrast to the results with the 259-bp duplex, hRPA had only a very
minor effect on the unwinding activity of BLM on the 851-bp duplex even
at the highest concentration of BLM tested, 64 nM (Fig. 4).
These results suggest that BLM helicase, even in the presence of hRPA,
fails to appreciably unwind very long DNA duplexes.
BLM Helicase Poorly Unwinds the 851-bp Duplex Over Prolonged
Incubation--
Previously, we demonstrated that hRPA enables WRN
helicase to unwind a long 849-bp partial duplex DNA substrate in a
time-dependent manner (29). To explore the possibility that
BLM helicase could effectively unwind longer DNA duplexes than 259 bp
given sufficiently long periods of incubation, the BLM helicase was
tested for unwinding of the 851-bp partial duplex over a 3-h period in
the presence of hRPA. However, this kinetic analysis of the BLM
helicase reaction demonstrated only slight displacement of the 851-mer
(~ 4%) in reactions containing up to 40 nM BLM monomer
(data not shown).
Effect of hRPA on ATPase Activity--
To address the mechanism by
which hRPA stimulates BLM helicase activity, we measured the effect of
hRPA on ssDNA-stimulated ATPase activity of BLM (Table
II). The turnover rate constant kcat for ATP hydrolysis by BLM helicase was
determined at various concentrations of hRPA protein and compared with
the kcat value obtained in the absence of hRPA.
As shown in Table II, there was minimal effect of hRPA on
kcat values for BLM-catalyzed ATPase activity
using the DNA effector (dT)~263. A modest increase of
approximately 1.5-fold was detected at hRPA concentrations of 32 and 64 nM heterotrimer. Likewise, a minor increase in BLM-specific ATPase activity was also observed at these concentrations of hRPA using
M13mp18 ssDNA circles as the effector. These results suggest that hRPA
does not significantly increase the specific ATPase activity of BLM
protein. At the highest concentration of hRPA tested, there is a
significant decrease in the ATPase reaction rate using M13mp18 ssDNA as
the effector. This inhibition may reflect competition between hRPA and
BLM helicase for ssDNA-binding sites on the M13 ssDNA, or inhibition of
translocation of BLM helicase along ssDNA (see "Discussion").
Alternatively, a physical interaction between BLM and hRPA may inhibit
BLM ATPase activity in the presence of M13 ssDNA, although this does
not seem likely since the effect does not occur in the presence of
(dT)~263.
View this table:
[in this window]
[in a new window]
|
Table II
The effect of hRPA on the Kcat for ATP hydrolysis catalyzed
by BLM
The concentration of BLM in each reaction was 13 nM.
|
|
BLM Forms a Direct Complex with hRPA ELISA Studies--
The
specific functional interaction between hRPA and BLM helicase suggested
to us that the two proteins physically interact with one another.
ELISAs were used to test for a protein-protein interaction. Increasing
amounts of BLM protein were incubated in helicase reaction buffer
containing 50 mM NaCl and 100 µg/ml BSA with hRPA that
had been immobilized on polystyrene microtiter wells. Bound BLM protein
was detected immunologically. As shown in Fig.
5, the colorimetric signal was both
dose-dependent and saturable. The specificity of this
interaction was demonstrated by the absence of color in wells that had
been precoated with BSA rather than hRPA (data not shown). In control
experiments, the colorimetric signal from the BLM-hRPA interaction was
resistant to pretreatment of both BLM protein and hRPA with DNase I
suggesting that a contaminating DNA bridge is not responsible for the
signal (data not shown). The specific binding of BLM protein to the
hRPA-coated wells was analyzed according to Scatchard binding theory.
The data were analyzed by a Hill plot as described under "Materials and Methods." The transformed data were linear indicating a single set of binding sites for hRPA with BLM protein. The apparent
dissociation constant (Kd) was determined to be 1.3 nM.

View larger version (11K):
[in this window]
[in a new window]
|
Fig. 5.
Detection of a BLM·hRPA complex by
ELISA. hRPA-coated wells (15 nM, heterotrimer,
application) were incubated with increasing amounts of BLM protein for
30 min at 24 °C. Wells were aspirated and washed three times, and
bound BLM protein was detected by ELISA using a rabbit polyclonal
antibody against BLM protein. Absorbance readings at each point were
corrected by subtracting a background A450
reading generated with BSA-coated wells.
|
|
We next examined the salt dependence of the BLM-hRPA interaction (Fig.
6). 100 ng of BLM protein (6.3 nM, monomer) was incubated in helicase reaction buffer
containing the indicated concentrations of sodium chloride with hRPA
that had been precoated on the microtiter wells. The BLM-hRPA
interaction was nearly completely resistant to sodium chloride
concentrations up to 150 mM. The protein interaction was
reduced by 15% at a sodium chloride concentration of 200 mM. Further reduction in the BLM-hRPA interaction was
detected as the salt concentration was increased up to 400 mM. However, a significant fraction (30%) of the
BLM·hRPA complexes was resistant to dissociation at sodium chloride
concentrations up to 600 mM.

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 6.
The effect of NaCl concentration on the
binding of BLM protein to immobilized hRPA. Various concentrations
of NaCl (0-600 mM) were included in the initial solution
used for incubation of BLM protein with hRPA bound to the microtiter
well. ELISAs were conducted as described under "Materials and
Methods."
|
|
Far Western Studies--
In order to confirm the results of the
ELISA studies, and to identify the subunit(s) of hRPA that mediates the
interaction with BLM, Far Western analysis was performed (see
"Materials and Methods"). For this, hRPA was immobilized on a
nitrocellulose filter, which was then incubated with purified BLM
protein. The filter was then washed to remove unbound protein, and the
presence of BLM was detected by conventional Western blotting. As
controls, the membrane also contained topoisomerase III
, which was
very recently shown to bind BLM (35), BSA, and BLM itself. Moreover, a
second filter was prepared containing the same proteins, which was
incubated in buffer alone. Fig. 7 shows
that the anti-BLM antibody detected a band at the position of the
70-kDa subunit of the hRPA preparation (as well as some minor
degradation products of this subunit), as well as at the position of
the topoisomerase III
-positive control. No band was seen at the
positions of either the BSA-negative control or the 32- and 14-kDa
subunits of RPA. The immunoreactivity at the position of the 70-kDa
hRPA subunit was not due to cross-reactivity of the anti-BLM antiserum
with hRPA, because this band was absent from the control blot that had
been incubated with buffer alone. The BLM present on the control membrane confirmed that the Western blotting procedure was successful for each membrane. From these studies, we conclude that BLM binds to
the 70-kDa subunit of hRPA.

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 7.
BLM and hRPA interact via the 70-kDa subunit
of hRPA. Purified hRPA, topoisomerase III , BSA and BLM (as
indicated above the lanes) were subjected to
SDS-polyacrylamide gel electrophoresis on three identical gels.
a, the proteins were stained with Coomassie Blue.
b and c, the proteins were transferred to
nitrocellulose membrane and then incubated with either purified BLM
(b, +BLM) or buffer alone (c, BLM).
Western blotting using anti-BLM antibody was then used to detect the
presence of BLM on each membrane. The positions of the 70-, 32-, and
14-kDa subunits of hRPA are indicated on the left. The
positions of the molecular mass standards running parallel are shown on
the right.
|
|
 |
DISCUSSION |
The cellular and molecular roles of the BLM gene
product remain to be defined and characterized. Recently, it was shown
that missense alleles of Bloom's syndrome abolish the ATPase and
helicase activities of the BLM protein and fail to correct the genomic instability of Bloom's syndrome cells (26, 27). These findings indicate that the catalytic activities of the BLM protein play an
essential role in the maintenance of genomic integrity. However, the
precise defects in DNA metabolic pathways that give rise to the
cellular and clinical phenotypes of BS remain to be elucidated. To
understand better the functional roles of the BLM protein, we have
examined the catalytic activities of the BLM protein and the effect of
hRPA on its activities. The single-stranded DNA-binding protein RPA has
been well characterized and implicated in the processes of replication,
recombination, and repair. The results presented here suggest that BLM
and hRPA are likely to function together in one of these fundamental processes.
In this study, we demonstrate a functional interaction between BLM and
RPA. hRPA stimulates BLM helicase activity on DNA duplexes ranging from
30 to 259 bp. scRPA was also shown to stimulate BLM helicase activity
on the 259-bp partial duplex substrate. A specific interaction between
BLM helicase and RPA is supported by the absolute requirement for RPA
in the BLM-catalyzed unwinding of the 259-bp duplex. Two heterologous
SSBs, ESSB and T4 gp32, both failed to stimulate BLM-catalyzed
unwinding of the 259-bp partial duplex as well as a 71-bp duplex (data
not shown). These results suggest that an additional role of SSB in the
BLM-catalyzed helicase reaction is performed by RPA other than simply
coating the single strands generated during DNA duplex unwinding and
preventing reannealing of separated strands.
An important property of DNA helicases is their dependence of unwinding
on duplex length. Many helicases exhibit a limited reaction mechanism
in which the fraction of DNA duplex molecules unwound decreases
substantially as the duplex length increases (36). Our analysis of
helicase activity as a function of BLM protein concentration on
increasing length DNA duplexes reveals that BLM helicase belongs to
this class of enzymes that catalyze a limited unwinding reaction. Very
little unwinding of the 259- or 851-bp duplexes is detected at BLM
protein concentrations that unwind nearly all of the 30- or 71-bp
substrate molecules. Thus BLM helicase, acting alone, unwinds only
relatively short DNA duplexes.
The limited unwinding reaction of BLM helicase is overcome by the
participation of RPA. Both human and yeast RPA, which display a high
level of homology (28), are able to stimulate the BLM-catalyzed unwinding reaction. It is possible, therefore, that RPA interacts functionally with the Sgs1 helicase in yeast. The effect of hRPA on the
BLM helicase reaction is demonstrated by comparing BLM unwinding
activity on different length DNA duplex substrates in the absence and
presence of hRPA as a function of BLM concentration (Figs. 1 and 4). On
the short 30-bp partial duplex substrate, a small (1.6-fold)
stimulatory effect of hRPA on the BLM helicase reaction was detected at
the lowest concentration of BLM tested, 2 nM monomer. At
higher concentrations of BLM, the difference between reactions in the
presence and absence of hRPA was reduced as the substrate unwound
reached a maximum (approximately 90%). On the 71-bp partial duplex, a
difference was only detected at higher concentrations of BLM (32 and 64 nM monomer). In the hRPA-supported reaction, the extent of
unwinding the 71-bp duplex reaches >90% substrate unwound compared
with approximately 60% of the substrate unwound in reactions lacking
hRPA. A number of explanations are possible. Based on the high affinity
of hRPA for ssDNA, the difference may partly reflect inhibition of
reannealing of the displaced strand during unwinding.
However, an additional effect of hRPA on BLM unwinding is evident based
on the inability of heterologous SSBs to stimulate BLM helicase
activity on the 71-bp partial duplex or the 259-bp partial duplex (data
not shown).
The most obvious effect of hRPA on BLM helicase activity was observed
with the 259-bp partial duplex. A 17-fold increase in duplex unwinding
was detected at a BLM concentration of 16 nM monomer when
hRPA (144 nM, heterotrimer) was present, and a 38-fold difference between helicase reactions conducted in the presence versus absence of hRPA was detected at a BLM concentration
of 32 nM monomer. Previously, the longest DNA duplex
reported to be unwound by BLM helicase was 91 bp. These results
demonstrate a functional requirement of hRPA for BLM-catalyzed
unwinding of the 259-bp DNA duplex substrate. However, hRPA does not
stimulate BLM helicase to unwind effectively the 851-bp partial duplex
substrate, even over a prolonged 3-h incubation. We conclude that the
stimulatory effect of hRPA on the BLM unwinding activity is limited to
partial duplex substrates of
259 bp, at least under the reaction
conditions described here.
If BLM helicase unwinds substantially long duplex tracts (
851-bp)
in vivo, an additional factor is likely to be necessary for
efficient unwinding. The inability of RPA to stimulate BLM-catalyzed unwinding of the long 851-bp duplex suggests a difference from the
previously demonstrated WRN-RPA interaction. In the WRN-RPA interaction, a significant percentage of the 849-bp M13 partial duplex
was unwound (up to 30% substrate unwound in 2 h) (29). However,
the conditions for the WRN and BLM helicase reactions are different
from one another, and we cannot rule out that BLM helicase may be able
to unwind the 851-bp duplex under other reaction conditions.
Specific stimulation of BLM helicase activity by RPA suggests that the
two proteins functionally interact. However, hRPA does not increase the
specific ATPase activity of BLM protein suggesting that the observed
increase in helicase activity is not due to a greater rate of ATP
hydrolysis. We did observe a 4-fold inhibition of BLM ATP hydrolysis in
the presence of the M13 ssDNA circle effector at the highest
concentration of hRPA tested (256 nM heterotrimer) (Table
II). At an hRPA concentration of 256 nM heterotrimer, the ratio of ssDNA binding equivalents over ssDNA-binding sites (R) in the
ATPase reaction is 0.24. Despite the fact that 75% of the ssDNA-binding sites would be vacant, it is possible that a direct competition between hRPA and BLM helicase for binding sites on the
M13mp18 ssDNA circle contributes to the inhibition of BLM ATPase
activity at the very high concentration of hRPA. The 6-8-fold stimulation of ATP hydrolysis in the presence of long dT tracts or
circular M13 ssDNA molecules compared with (dT)16 (see
Table I) may be explained by the longer time that BLM protein exists in
the DNA-bound state. The results may be interpreted to suggest that BLM
protein translocates processively along an ssDNA effector. The
translocation of BLM enzyme along ssDNA may be hindered by the presence
of bound hRPA molecules. However, the inhibitory effect is specific to
the M13 ssDNA circle as it was not observed with
(dT)~263. The basis for this difference is not known but
may reflect different binding properties of hRPA for the two DNA effectors.
The unwinding activity of WRN helicase (29) and human helicase
(39), like BLM, is stimulated by hRPA. However, the ssDNA-stimulated ATPase activity of these helicases is not stimulated by hRPA. Although
hRPA does not appear to increase the processivity of these enzymes
during translocation along ssDNA, hRPA may play a role in the
recruitment of the helicase to the ssDNA-double-stranded DNA junction
of the ongoing helicase reaction. Consistent with this notion, we found
that the unwinding activity of BLM helicase was not stimulated by hRPA
on a 102-bp blunt duplex DNA substrate (data not shown). These data
would suggest that an ssDNA loading dock is a requirement for the
functional interaction between BLM helicase and hRPA. In addition, hRPA
may tether BLM helicase to the DNA substrate at the unwinding fork to
facilitate progression of the helicase through relatively long DNA
duplex tracts.
A functional interaction between BLM and hRPA is strongly supported by
our demonstration of a physical interaction between the two proteins
that is mediated via the 70-kDa subunit of hRPA. ELISA experiments
demonstrate that the physical interaction is saturable and shows a high
affinity interaction between BLM protein and hRPA
(Kd = 1.3 nM). The BLM·hRPA complex is
resistant to salt concentrations up to 200 mM, indicating a
fairly stable interaction. The physical interaction between BLM and
hRPA presumably mediates the specific stimulatory effect of hRPA on BLM
helicase activity. This is the first reported functional interaction
between BLM helicase and another protein. WRN protein also exhibits a functional and physical interaction with hRPA (29), raising the
possibility that the two helicases, defective in two distinct genomic
instability disorders, compete for hRPA in DNA metabolic pathways.
Further studies are necessary to address the importance of the WRN/BLM
helicase interaction with hRPA and other molecular partners in pathways
defective in these syndromes.
The demonstration of a physical and functional interaction between BLM
and hRPA suggests that the two proteins function together in some
aspect of DNA metabolism in vivo. Recently, BLM protein was
shown to colocalize with RPA in meiotic prophase nuclei of mouse
spermatocytes (30). RPA has been previously shown to play a role in
both homologous synapsis and recombination. The appearance of BLM
protein is delayed relative to RPA at the synaptonemal complex,
suggesting the involvement of BLM in a late stage of zygotene DNA
replication or meiotic synapsis. The colocalization of BLM protein and
RPA supports the notion that these proteins may functionally interact
to generate ssDNA during meiotic synapsis. This suggestion is
consistent with the results reported here that characterize a specific
functional and physical interaction between BLM and hRPA.
The elevated sister chromatid exchange and hyper-recombination
associated with BS suggest a defect in recombination. However, a
replication defect may be primarily responsible for the genomic instability. BS fibroblasts display reduced replication fork
progression and the accumulation of abnormal replication intermediates
(10). BLM helicase (and other RecQ family helicases) have been proposed to be important to overcome structural abnormalities that arise during
replication (2). It is conceivable that BLM helicase and RPA act
together to unwind various types of nucleic acid structures at the
replication fork, thereby facilitating efficient DNA replication or
recombination. The specific interaction between BLM and hRPA suggests
that these proteins are likely to function coordinately in
vivo. The characteristic cellular and clinical phenotypes of BS
suggest that unique interactions of BLM protein with DNA and cellular
proteins such as RPA are critical to the biological function of the
BLM-catalyzed unwinding reaction necessary to maintain genomic
integrity in vivo.
 |
ACKNOWLEDGEMENTS |
We thank the Danish Center for
Molecular Gerontology for interactions. We thank Brian Howard of
Paragon Bioservices for technical assistance in the ELISA studies.
 |
FOOTNOTES |
*
This work was supported in part by National Institutes of
Health Grant CA71612 (to M. K. K.).The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
Supported by the Imperial Cancer Research Fund.
**
A Boehringer Ingelheim Fonds Fellow.

To whom correspondence should be addressed: Laboratory of
Molecular Genetics, NIA, National Institutes of Health, 5600 Nathan Shock Dr., Baltimore, MD 21224. E-mail: vbohr@nih.gov.
Published, JBC Papers in Press, May 23, 2000, DOI 10.1074/jbc.M001557200
 |
ABBREVIATIONS |
The abbreviations used are:
BS, Bloom's
syndrome;
bp, base pair;
RPA, replication protein A;
hRPA, human RPA;
SSB, single-stranded binding protein;
ESSB, E. coli SSB;
scRPA S. cerevisiae replication protein A, ssDNA,
single-stranded DNA;
BSA, bovine serum albumin;
PBS, phosphate-buffered
saline;
ELISA, enzyme-linked immunosorbent assay;
nt, nucleotide.
 |
REFERENCES |
| 1.
|
German, J.
(1993)
Medicine (Baltimore)
72,
393-406
|
| 2.
|
Chakraverty, R. K.,
and Hickson, I. D.
(1999)
BioEssays
21,
286-294
|
| 3.
|
Ellis, N. A.,
and German, J.
(1996)
Hum. Mol. Genet.
5,
1457-1463
|
| 4.
|
Watt, P. M.,
Hickson, I. D.,
Borts, R. H.,
and Louis, E. J.
(1996)
Genetics
144,
935-945
|
| 5.
|
Langlois, R. G.,
Bigbee, W. L.,
Jensen, R. H.,
and German, J.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
670-674
|
| 6.
|
Cheng, R. Z.,
Murano, S.,
Kurz, B.,
and Shmookler, R. R.
(1990)
Mutat. Res.
237,
259-269
|
| 7.
|
Ellis, N. A.,
Groden, J.,
Ye, T. Z.,
Straughen, J.,
Lennon, D. J.,
Ciocci, S.,
Proytcheva, M.,
and German, J.
(1995)
Cell
83,
655-666
|
| 8.
|
Gianneli, F.,
Benson, P. F.,
Pawsey, S. A.,
and Polani, P. E.
(1977)
Nature
265,
466-469
|
| 9.
|
Hanaoka, F.,
Yamada, M.,
Takeuchi, F.,
Goto, M.,
Miyamoto, T.,
and Hori, T.
(1985)
Adv. Exp. Med. Biol.
190,
439-457
|
| 10.
|
Lonn, U.,
Lonn, S.,
Nylen, U.,
Winblad, G.,
and German, J.
(1990)
Cancer Res.
50,
3141-3145
|
| 11.
|
Nakayama, K.,
Irino, N.,
and Nakayama, H.
(1985)
Mol. Gen. Genet.
200,
266-271
|
| 12.
|
Hanada, K.,
Ukita, T.,
Kohno, Y.,
Saito, K.,
Kato, J.,
and Ikeda, H.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
3860-3865
|
| 13.
|
Gangloff, S.,
McDonald, J. P.,
Bendixen, C.,
Arthur, L.,
and Rothstein, R.
(1994)
Mol. Cell. Biol.
14,
8391-8398
|
| 14.
|
Watt, P. M.,
Louis, E. J.,
Borts, R. H.,
and Hickson, I. D.
(1995)
Cell
81,
253-260
|
| 15.
|
Stewart, E.,
Chapman, C. R.,
Al-Khodairy, F.,
Carr, A. M.,
and Enoch, T.
(1997)
EMBO J.
16,
2682-2692
|
| 16.
|
Yu, C. E.,
Oshima, J.,
Fu, Y. H.,
Wijsman, E. M.,
Hisama, F.,
Alisch, R.,
Matthews, S.,
Nakura, J.,
Miki, T.,
Ouais, S.,
Martin, G. M.,
Mulligan, J.,
and Schellenberg, G. D.
(1996)
Science
272,
258-262
|
| 17.
|
Seki, M.,
Miyazawa, H.,
Tada, S.,
Yanagisawa, J.,
Yamaoka, T.,
Hoshino, S.,
Ozawa, K.,
Eki, T.,
Nogami, M.,
and Okumura, K.
(1994)
Nucleic Acids Res.
22,
4566-4573
|
| 18.
|
Kitao, S.,
Ohsugi, I.,
Ichikawa, K.,
Goto, M.,
Furuichi, Y.,
and Shimamoto, A.
(1998)
Genomics
54,
443-452
|
| 19.
|
Kitao, S.,
Shimamoto, A.,
Goto, M.,
Miller, R. W.,
Smithson, W. A.,
Lindor, N. M.,
and Furuichi, Y.
(1999)
Nat. Genet.
22,
82-84
|
| 20.
|
Salk, D.,
Bryant, E.,
Hoehn, H.,
Johnston, P.,
and Martin, G. M.
(1985)
Adv. Exp. Med. Biol.
190,
305-311
|
| 21.
|
Salk, D.,
Au, K.,
Hoehn, H.,
and Martin, G. M.
(1981)
Cytogenet. Cell Genet.
30,
92-107
|
| 22.
|
Lindor, N. M.,
Devries, E. M.,
Michels, V. V.,
Schad, C. R.,
Jalal, S. M.,
Donovan, K. M.,
Smithson, W. A.,
Kvols, L. K.,
Thibodeau, S. N.,
and Dewald, G. W.
(1996)
Clin. Genet.
49,
124-129
|
| 23.
|
Karow, J. K.,
Chakraverty, R. K.,
and Hickson, I. D.
(1997)
J. Biol. Chem.
272,
30611-30614
|
| 24.
|
Sun, H.,
Karow, J. K.,
Hickson, I. D.,
and Maizels, N.
(1998)
J. Biol. Chem.
273,
27587-27592
|
| 25.
|
Karow, J. K.,
Newman, R. H.,
Freemont, P. S.,
and Hickson, I. D.
(1999)
Curr. Biol.
9,
597-600
|
| 26.
|
Neff, N. F.,
Ellis, N. A.,
Ye, T. Z.,
Noonan, J.,
Huang, K.,
Sanz, M.,
and Proytcheva, M.
(1999)
Mol. Biol. Cell
10,
665-676
|
| 27.
|
Bahr, A.,
De Graeve, F.,
Kedinger, C.,
and Chatton, B.
(1998)
Oncogene
17,
2565-2571
|
| 28.
|
Wold, M. S.
(1997)
Annu. Rev. Biochem.
66,
61-92
|
| 29.
|
Brosh, R. M., Jr.,
Orren, D. K.,
Nehlin, J. O.,
Ravn, P. H.,
Kenny, M. K.,
Machwe, A.,
and Bohr, V. A.
(1999)
J. Biol. Chem.
274,
18341-18350
|
| 30.
|
Walpita, D.,
Plug, A. W.,
Neff, N. F.,
German, J.,
and Ashley, T.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
5622-5627
|
| 31.
|
Kenny, M. K.,
Schlegel, U.,
Furneaux, H.,
and Hurwitz, J.
(1990)
J. Biol. Chem.
265,
7693-7700
|
| 32.
|
Lechner, R. L.,
and Richardson, C. C.
(1983)
J. Biol. Chem.
258,
11185-11196
|
| 33.
|
Matson, S. W.,
and George, J. W.
(1987)
J. Biol. Chem.
262,
2066-2076
|
| 34.
|
Matson, S. W.,
and Richardson, C. C.
(1983)
J. Biol. Chem.
258,
14009-14016
|
| 35.
|
Wu, L.,
Davies, S. L.,
North, P. S.,
Goulaouic, H.,
Riou, J.-F.,
Turley, H.,
Gatter, K. C.,
and Hickson, I. D.
(2000)
J. Biol. Chem.
275,
9636-9646
|
| 36.
|
Matson, S. W.,
Bean, D. W.,
and George, J. W.
(1994)
BioEssays
16,
13-22
|
| 37.
|
Lohman, T. M.,
and Ferrari, M. E.
(1994)
Annu. Rev. Biochem.
63,
527-570
|
| 38.
|
Sibenaller, Z. A.,
Sorensen, B. R.,
and Wold, M. S.
(1998)
Biochemistry
37,
12496-12506
|
| 39.
|
Seo, Y. S.,
Lee, S. H.,
and Hurwitz, J.
(1991)
J. Biol. Chem.
266,
13161-13170
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us